| EPB256 | Impact of COVID-19 pandemic on HIV treatment services in 12 PEPFAR-supported sites in 8 provinces, Thailand, 2021 | E-poster | Impact of COVID-19 on HIV care |
| PEMOD58 | Impact of Covid-19 prevention measures including restrictions on socio-economic lives of people living with, at high risk of and those affected byhivonaccess, utilization of essential health services | Poster exhibition | COVID-19 social distancing and curfews: Implications for access to HIV care |
| PEMOE41 | Impact of COVID-19 public health measures on ART use among Ugandans living with HIV in sero-different couples | Poster exhibition | Impact of COVID-19 on HIV treatment services |
| EPE411 | Impact of crisis-driven interventions on averting Lost to follow-up among people living with HIV on antiretroviral therapy in Mumbai, India | E-poster | Impact of COVID-19 on HIV treatment services |
| EPE069 | Impact of Daily Situation Rooms (analysis) in increasing linkage to care among people living with HIV | E-poster | Implementation science of scaling up HIV treatment |
| EPB128 | Impact of differentiated service delivery models on retention and viral load suppression among ART clients in Katakwi Destrict | E-poster | Other ART complications and adverse reactions |
| EPB252 | Impact of Dolutegravir (DTG) on viral load suppression and HIV Drug Resistance (HIVDR) among Zambian children on ART: Results from the pediatric Acquired HIVDR (pADR) national survey | E-poster | Resistance to ART |
| EPA012 | Impact of early ART initiation on the dynamics of regulatory CD8 T-cells in acute HIV infection | E-poster | Systemic immune activation and inflammation |
| OAB0103 | Impact of gender identity- and HIV-related stigmas and psychosocial resources on mental health and alcohol use among transgender women newly diagnosed with HIV in India: a longitudinal cohort study | Oral abstract session with live Q&A | Mental health (including depression and psychiatric manifestations) and HIV |
| EPB098 | Impact of HCV treatment on markers of kidney disease among persons with monoinfection and HCV/HIV co-infection | E-poster | Renal disease |